Novavax Inc. sell JPMorgan Chase & Co.
Start price
18.11.25
/
50%
€5.63
Target price
18.11.26
€5.18
Performance (%)
-0.55%
Price
12.12.25
€5.60
Summary
This prediction is currently active. Since the start of the prediction for Novavax Inc. the price has only changed by -0.55%. This prediction currently runs until 18.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Novavax Inc. | -5.548% |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat